Yu Huang - Biography#

Yu Huang currently serves as the Chair Professor of Biomedical Sciences and Vascular Biology and the Head of the Department of Biomedical Sciences at City University of Hong Kong (CityUHK), China. He obtained his Bachelor of Science degree from Fudan University Shanghai Medical College and his Doctor of Philosophy degree from the University of Cambridge. Prior to assuming his position at CityUHK in September 2021, he served as the A3 Professor of Biomedical Sciences and the inaugural Director (Basic Sciences) of the Heart and Vascular Institute at The Chinese University of Hong Kong, China.

He has previously served as the President of the Asian Society for Vascular Biology (2010 - 2018) and as the Vice-President of the Chinese Society for Vascular Medicine (2015 - 2021). He currently serves as Vice-President of the Chinese Section of the International Society for Heart Research (2016 - present) and as Vice-President of the Chinese Association of Physiological Sciences (2022 - present). He is a member of the International Council of the International Society for Heart Research (2025 - present), He is an elected Fellow of the International Society for Heart Research (2019), the International Union of Physiological Sciences (IUPS) Academy of Physiology (2023), and the British Pharmacological Society (2023). He was the inaugural recipient of the Hong Kong Research Grants Council–Senior Research Fellow Award.

He serves as a member of Grant Review Panel for the Hong Kong Research Grants Council, Hong Kong Government’s Health and Medical Research Fund, the Innovation and Technology Fund (ITF), Hong Kong Government’s Innovation and Technology Commission (2023-), the Natural Science Foundation of China, and the University of Macau Multi-Year Research Grant. He has so far served (past and present) as the editor, guest editor, associate editor, and editorial board member for 18 SCI-indexed journals. He is the first Chinese national to serve as an Associate Editor for Circulation Research (2019-), a preeminent journal in cardiovascular biology and medicine of the American Heart Association. He has reviewed grant proposals for 35 granting agencies of 14 countries and regions. He also serves as a visiting or guest professor at 12 universities and institutes.

The research focus of his team is to elucidate cellular and molecular events in initiation and progression of endothelial cell dysfunction in hypertension, obesity, and diabetes, to uncover novel biomarkers for vascular pathogenesis, and to develop venues to reverse vascular dysfunction in animal models of cardio-metabolic disorders. He has co-authored 524 publications in SCI-indexed journals including Nature, Science, Cell Metabolism, Circulation Research, European Heart Journal, PNAS, Diabetes, Hypertension, ATVB, Stroke with >37150 Google Scholar citations and h-index of 99.